{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:26:40Z","timestamp":1787506000328,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.gene.2025.149633","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T10:53:11Z","timestamp":1749898391000},"page":"149633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Thiolutin alleviates DNCB-induced atopic dermatitis-like symptoms via the inactivation of NLRP3 inflammasome"],"prefix":"10.1016","volume":"964","author":[{"given":"Jing","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liehua","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.gene.2025.149633_b0005","first-page":"224","article-title":"Atopic dermatitis in children and adults\u2014diagnosis and treatment","volume":"120","author":"Wollenberg","year":"2023","journal-title":"Deutsches Arzteblatt International."},{"issue":"6","key":"10.1016\/j.gene.2025.149633_b0010","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/bjd\/ljae344","article-title":"An expert consensus on managing dupilumab-related ocular surface disorders in people with atopic dermatitis 2024","volume":"191","author":"Ardern-Jones","year":"2024","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.gene.2025.149633_b0015","article-title":"Counting the burden: atopic dermatitis and health-related quality of life","volume":"100(12):adv00161","author":"Ali","year":"2020","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.gene.2025.149633_b0020","article-title":"Molecular mechanisms of atopic dermatitis pathogenesis","volume":"22(8)doi:10.3390\/ijms22084130","author":"Sroka-Tomaszewska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.gene.2025.149633_b0025","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s40257-022-00712-0","article-title":"What's new in topicals for atopic dermatitis?","volume":"23","author":"Kleinman","year":"2022","journal-title":"Am. J. Clin. Dermatol."},{"issue":"1","key":"10.1016\/j.gene.2025.149633_b0030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41573-021-00266-6","article-title":"Atopic dermatitis: an expanding therapeutic pipeline for a complex disease","volume":"21","author":"Bieber","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.gene.2025.149633_b0035","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15636","article-title":"Comparative efficacy and safety of abrocitinib, baricitinib, and upadacitinib for moderate-to-severe atopic dermatitis: a network meta-analysis","volume":"35","author":"Wan","year":"2022","journal-title":"Dermatol. Ther."},{"issue":"Pt C","key":"10.1016\/j.gene.2025.149633_b0040","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.semcdb.2023.04.005","article-title":"Epigenetic control of inflammation in atopic dermatitis","volume":"154","author":"Akhtar","year":"2024","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.gene.2025.149633_b0045","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8878153","article-title":"Cicadidae periostracum attenuates atopic dermatitis symptoms and pathology via the regulation of NLRP3 inflammasome activation","volume":"2021","author":"Park","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.gene.2025.149633_b0050","doi-asserted-by":"crossref","unstructured":"Kim KM, Kim SY, Mony TJ, et al. Moringa concanensis L. Alleviates DNCB-Induced Atopic Dermatitis-like Symptoms by Inhibiting NLRP3 Inflammasome-Mediated IL-1\u03b2 in BALB\/c Mice. Pharmaceuticals (Basel, Switzerland). 2022;15(10)doi:10.3390\/ph15101217.","DOI":"10.3390\/ph15101217"},{"key":"10.1016\/j.gene.2025.149633_b0055","doi-asserted-by":"crossref","unstructured":"Kim SY, Sapkota A, Bae YJ, et al. The Anti-Atopic Dermatitis Effects of Mentha arvensis Essential Oil Are Involved in the Inhibition of the NLRP3 Inflammasome in DNCB-Challenged Atopic Dermatitis BALB\/c Mice. International journal of molecular sciences. 2023;24(9)doi:10.3390\/ijms24097720.","DOI":"10.3390\/ijms24097720"},{"issue":"5","key":"10.1016\/j.gene.2025.149633_b0060","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/intimm\/dxx018","article-title":"Mechanisms governing inflammasome activation, assembly and pyroptosis induction","volume":"29","author":"Kesavardhana","year":"2017","journal-title":"Int. Immunol."},{"issue":"2","key":"10.1016\/j.gene.2025.149633_b0065","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.gene.2025.149633_b0070","doi-asserted-by":"crossref","first-page":"8009","DOI":"10.2147\/JIR.S484919","article-title":"Arctiin alleviates atopic dermatitis against inflammation and pyroptosis through suppressing TLR4\/MyD88\/NF-\u03baB and NLRP3\/Caspase-1\/GSDMD signaling pathways","volume":"17","author":"Li","year":"2024","journal-title":"J. Inflamm. Res."},{"issue":"6","key":"10.1016\/j.gene.2025.149633_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0104-3","article-title":"Atopic dermatitis-like skin lesions are suppressed in fat-1 transgenic mice through the inhibition of inflammasomes","volume":"50","author":"Jang","year":"2018","journal-title":"Exp. Mol. Med."},{"issue":"10","key":"10.1016\/j.gene.2025.149633_b0080","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/s41419-021-04159-9","article-title":"A novel function of NLRP3 independent of inflammasome as a key transcription factor of IL-33 in epithelial cells of atopic dermatitis","volume":"12","author":"Zheng","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.gene.2025.149633_b0085","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abe2933","article-title":"Pharmacological targeting of NLRP3 deubiquitination for treatment of NLRP3-associated inflammatory diseases","author":"Ren","year":"2021","journal-title":"Sci. Immunol."},{"issue":"3","key":"10.1016\/j.gene.2025.149633_b0090","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00221-023-06566-0","article-title":"Thiolutin attenuates ischemic stroke injury via inhibition of NLRP3 inflammasome: an in vitro and in vivo study","volume":"241","author":"Jia","year":"2023","journal-title":"Exp. Brain Res."},{"issue":"2","key":"10.1016\/j.gene.2025.149633_b0095","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/08923973.2023.2298894","article-title":"Thiolutin, a selective NLRP3 inflammasome inhibitor, attenuates cyclophosphamide-induced impairment of sperm and fertility in mice","volume":"46","author":"Zhu","year":"2024","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"7","key":"10.1016\/j.gene.2025.149633_b0100","doi-asserted-by":"crossref","first-page":"e877","DOI":"10.1002\/iid3.877","article-title":"Evidence on the therapeutic role of thiolutin in imiquimod-induced psoriasis-like skin inflammation in mice","volume":"11","author":"Wang","year":"2023","journal-title":"Immun. Inflammation Dis."},{"key":"10.1016\/j.gene.2025.149633_b0105","doi-asserted-by":"crossref","DOI":"10.3791\/65120","article-title":"A mouse ear model for allergic contact dermatitis evaluation","author":"Shao","year":"2023","journal-title":"Journal of Visualized Experiments: JoVe."},{"issue":"4","key":"10.1016\/j.gene.2025.149633_b0110","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods (san Diego, Calif)."},{"issue":"1","key":"10.1016\/j.gene.2025.149633_b0115","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1600-065X.2011.01027.x","article-title":"Atopic dermatitis: a disease of altered skin barrier and immune dysregulation","volume":"242","author":"Boguniewicz","year":"2011","journal-title":"Immunol. Rev."},{"issue":"10023","key":"10.1016\/j.gene.2025.149633_b0120","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0140-6736(15)00149-X","article-title":"Atopic dermatitis","volume":"387","author":"Weidinger","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.gene.2025.149633_b0125","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jaad.2014.11.024","article-title":"A systematic review of topical corticosteroid withdrawal (\u201csteroid addiction\u201d) in patients with atopic dermatitis and other dermatoses","volume":"72","author":"Hajar","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"10.1016\/j.gene.2025.149633_b0130","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5114\/pdia.2013.35619","article-title":"Topical calcineurin inhibitors in dermatology. Part I: properties, method and effectiveness of drug use","volume":"30","author":"Gutfreund","year":"2013","journal-title":"Postepy Dermatol Alergol."},{"issue":"1","key":"10.1016\/j.gene.2025.149633_b0135","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaad.2014.03.023","article-title":"Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies","volume":"71","author":"Eichenfield","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"issue":"12","key":"10.1016\/j.gene.2025.149633_b0140","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1111\/exd.14412","article-title":"Mdivi-1 alleviates atopic dermatitis through the inhibition of NLRP3 inflammasome","volume":"30","author":"Li","year":"2021","journal-title":"Exp. Dermatol."},{"issue":"1","key":"10.1016\/j.gene.2025.149633_b0145","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/jid.2008.106","article-title":"Animal models of atopic dermatitis","volume":"129","author":"Jin","year":"2009","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.gene.2025.149633_b0150","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/exd.14270","article-title":"Mouse models of atopic dermatitis: a critical reappraisal","volume":"30","author":"Gilhar","year":"2021","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.gene.2025.149633_b0155","article-title":"Establishment and characterization of mild atopic dermatitis in the DNCB-induced mouse model","volume":"24(15)doi:10.3390\/ijms241512325","author":"Riedl","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.gene.2025.149633_b0160","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.2147\/JIR.S467327","article-title":"Preclinical models of atopic dermatitis suitable for mechanistic and therapeutic investigations","volume":"17","author":"Maskey","year":"2024","journal-title":"J. Inflamm. Res."},{"issue":"4","key":"10.1016\/j.gene.2025.149633_b0165","first-page":"2878","article-title":"Solanum nigrum Linne improves DNCB\u2011induced atopic dermatitis\u2011like skin disease in BALB\/c mice","volume":"22","author":"Hong","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.gene.2025.149633_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115160","article-title":"Artemisia annua water extract attenuates DNCB-induced atopic dermatitis by restraining Th2 cell mediated inflammatory responses in BALB\/c mice","volume":"291","author":"Han","year":"2022","journal-title":"J. Ethnopharmacol."},{"issue":"10","key":"10.1016\/j.gene.2025.149633_b0175","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.jsps.2022.07.003","article-title":"Angelica Yinzi alleviates 1-chloro-2,4-dinitrobenzene-induced atopic dermatitis by inhibiting activation of NLRP3 inflammasome and down-regulating the MAPKs\/NF-kB signaling pathway","volume":"30","author":"Liu","year":"2022","journal-title":"Saudi Pharm J."},{"key":"10.1016\/j.gene.2025.149633_b0180","doi-asserted-by":"crossref","unstructured":"Brunner PM. Early immunologic changes during the onset of atopic dermatitis. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2019;123(2):152-157. doi:10.1016\/j.anai.2019.03.033.","DOI":"10.1016\/j.anai.2019.03.033"},{"issue":"1","key":"10.1016\/j.gene.2025.149633_b0185","doi-asserted-by":"crossref","first-page":"13","DOI":"10.15570\/actaapa.2022.3","article-title":"The role of cytokines in atopic dermatitis: a breakthrough in immunopathogenesis and treatment","volume":"31","author":"Alsabbagh","year":"2022","journal-title":"Acta Dermatovenerologica Alpina, Pannonica, et Adriatica."},{"key":"10.1016\/j.gene.2025.149633_b0190","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.trsl.2016.02.011","article-title":"Emerging concepts: mast cell involvement in allergic diseases","volume":"174","author":"Modena","year":"2016","journal-title":"Transl. Res."},{"issue":"3","key":"10.1016\/j.gene.2025.149633_b0195","doi-asserted-by":"crossref","first-page":"102","DOI":"10.55133\/eji.300311","article-title":"NLRP3 inflammasome (rs10754558) gene polymorphism in patients with atopic dermatitis","volume":"30","author":"El Gendy","year":"2023","journal-title":"Egypt. J. Immunol."},{"key":"10.1016\/j.gene.2025.149633_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116344","article-title":"A homogeneous Lonicera japonica polysaccharide alleviates atopic dermatitis by promoting Nrf2 activation and NLRP3 inflammasome degradation via p62","volume":"309","author":"Bai","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.gene.2025.149633_b0205","article-title":"Coffea arabica extract attenuates atopic dermatitis-like skin lesions by regulating NLRP3 inflammasome expression and skin barrier functions","volume":"24(15)doi:10.3390\/ijms241512367","author":"Chang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.gene.2025.149633_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114440","article-title":"Thiolutin, a novel NLRP3 inflammasome inhibitor, mitigates IgA nephropathy in mice","volume":"152","author":"Zhang","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.gene.2025.149633_b0215","article-title":"Th17 cells in autoimmune and infectious diseases","volume":"2014","author":"Zambrano-Zaragoza","year":"2014","journal-title":"Int J Inflam."},{"issue":"5","key":"10.1016\/j.gene.2025.149633_b0220","first-page":"1092","article-title":"Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways","volume":"159","author":"Nograles","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.gene.2025.149633_b0225","article-title":"The IL-33\/IL-31 axis in allergic and immune-mediated diseases","volume":"24(11)doi:10.3390\/ijms24119227","author":"Murdaca","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.gene.2025.149633_b0230","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2147\/CCID.S257647","article-title":"IL-33\/13 axis and IL-4\/31 axis play distinct roles in inflammatory process and itch in psoriasis and atopic dermatitis","volume":"13","author":"Bodoor","year":"2020","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"issue":"9","key":"10.1016\/j.gene.2025.149633_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102350","article-title":"Emerging role of vitamin D in autoimmune diseases: an update on evidence and therapeutic implications","volume":"18","author":"Murdaca","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.gene.2025.149633_b0240","article-title":"IL-33\/IL-31 axis in immune-mediated and allergic diseases","volume":"20(23)doi:10.3390\/ijms20235856","author":"Murdaca","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.gene.2025.149633_b0245","article-title":"Anti-inflammatory and biologic drugs for atopic dermatitis: a therapeutic approach in children and adolescents","volume":"10","author":"Caffarelli","year":"2023","journal-title":"Front Med (lausanne)."},{"issue":"1","key":"10.1016\/j.gene.2025.149633_b0250","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1710-1492-9-30","article-title":"A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Allergy Asthma Clin. Immunol."},{"issue":"11","key":"10.1016\/j.gene.2025.149633_b0255","doi-asserted-by":"crossref","first-page":"773","DOI":"10.46747\/cfp.6911773","article-title":"Topical calcineurin inhibitors for atopic dermatitis","volume":"69","author":"Braschi","year":"2023","journal-title":"Can. Fam. Physician"},{"issue":"4","key":"10.1016\/j.gene.2025.149633_b0260","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s13555-020-00413-8","article-title":"Costs and treatment patterns among patients with atopic dermatitis using advanced therapies in the united states: analysis of a retrospective claims database","volume":"10","author":"Eichenfield","year":"2020","journal-title":"Dermatol Ther (heidelb)."},{"issue":"11","key":"10.1016\/j.gene.2025.149633_b0265","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s40265-024-02095-4","article-title":"Emerging biologic therapies for the treatment of atopic dermatitis","volume":"84","author":"Alvarenga","year":"2024","journal-title":"Drugs"}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111925004226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111925004226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T17:36:06Z","timestamp":1768844166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111925004226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":53,"alternative-id":["S0378111925004226"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2025.149633","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thiolutin alleviates DNCB-induced atopic dermatitis-like symptoms via the inactivation of NLRP3 inflammasome","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2025.149633","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"149633"}}